Mail

Australia markets open in 1 hour 8 minutes

ALL ORDS
7,386.70
+116.90(+1.61%)
AUD/USD
0.6549
-0.0008(-0.13%)
ASX 200
7,178.40
+116.80(+1.65%)
OIL
69.24
-3.08(-4.26%)
GOLD
2,043.10
+6.80(+0.33%)
Bitcoin AUD
66,828.80
-449.99(-0.67%)

FEELING THE PINCH?

Beat the cost-of-living squeeze with our pro tips and helpful hacks - sign up now

Radiopharm Theranostics Limited (RAD.AX)

ASX - ASX Delayed price. Currency in AUD

Add to watchlist

0.0750

+0.0040

(+5.63%)

At close: 04:10PM AEDT

Currency in AUD

Valuation measures⁴

Market cap (intra-day)	25.45M
Enterprise value	13.75M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	83.07
Price/book (mrq)	0.57
Enterprise value/revenue	47.03
Enterprise value/EBITDA	-0.44

Trading information

Stock price history

Beta (5Y monthly)	0.96
52-week change ³	-31.82%
S&P500 52-week change ³	16.10%
52-week high ³	0.2150
52-week low ³	0.0708
50-day moving average ³	0.0950
200-day moving average ³	0.1206

Share statistics

Avg vol (3-month) ³	294.02k
Avg vol (10-day) ³	88.91k
Shares outstanding ⁵	339.31M
Implied shares outstanding ⁶	339.31M
Float ⁸	178.52M
% held by insiders ¹	65.11%
% held by institutions ¹	1.06%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	30 June 2023
Most-recent quarter (mrq)	30 June 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	-850.24%

Management effectiveness

Return on assets (ttm)	-22.57%
Return on equity (ttm)	-63.78%

Income statement

Revenue (ttm)	6.21M
Revenue per share (ttm)	0.02
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	-13.32M
EBITDA	-25.29M
Net income avi to common (ttm)	-34.61M
Diluted EPS (ttm)	-0.1100
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	11.7M
Total cash per share (mrq)	0.03
Total debt (mrq)	N/A
Total debt/equity (mrq)	N/A
Current ratio (mrq)	1.23
Book value per share (mrq)	0.13

Cash flow statement

Operating cash flow (ttm)	-23.2M
Levered free cash flow (ttm)	-12.08M